PTSD Screening for Pregnant Women

N/A

Waitlist Available

Led By Briana Woods-Jaeger, PhD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18+ years old

Pregnant and in the first trimester attending initial prenatal care visit

Timeline

Screening 3 weeks

Treatment Varies

Follow Up initial ob visit (weeks 1-13), second trimester (weeks 14 to 27), third trimester (weeks 28-40), and 6-weeks postpartum

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare two different ways of screening for PTSD in Black pregnant women to see which one is better at improving their mental health, healthcare utilization, and birth outcomes.

Who is the study for?

This trial is for Black pregnant women who may have PTSD. It's designed to see if certain screening methods can help improve their mental health, satisfaction with care, and birth outcomes.

What is being tested?

The study compares two approaches: a brief screening for PTSD and a culturally responsive SBIRT (Screening, Brief Intervention, and Referral to Treatment) specifically tailored for obstetrics.

What are the potential side effects?

Since the interventions involve non-invasive screenings rather than medications or procedures, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am pregnant and in my first trimester, attending my first prenatal visit.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ initial ob visit (weeks 1-13), second trimester (weeks 14 to 27), third trimester (weeks 28-40), and 6-weeks postpartum

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~initial ob visit (weeks 1-13), second trimester (weeks 14 to 27), third trimester (weeks 28-40), and 6-weeks postpartum

This trial's timeline: 3 weeks for screening, Varies for treatment, and initial ob visit (weeks 1-13), second trimester (weeks 14 to 27), third trimester (weeks 28-40), and 6-weeks postpartum for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score

Secondary study objectives

Adequacy of prenatal care utilization (APNCU)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Culturally Responsive SBIRT for OBExperimental Treatment1 Intervention

Participants randomized to Culturally Responsive SBIRT for OB will participate in the intervention visit (20-30 minutes) while waiting for their OB visit (or after the visit if time does not allow) and then engage in their prenatal care visit as usual. If any safety concerns emerge during the visit, the lay provider will contact the clinical staff on the study

Group II: Brief Screening for PTSDExperimental Treatment1 Intervention

Participants randomized to Brief Screening For PTSD, screening will be conducted as part of regular clinic activities during the initial prenatal care visit. Specifically, clinic staff (nurse, PA) or study staff will ask the questions in the PC-PTSD-5 along with the standard procedure to administer the Edinburgh Postnatal Depression Scale (EPDS), and the provider will review the results with the patient during the prenatal care visit and provide referral resources regardless of screen outcome. Positive PTSD screens (PC-PTSD-5 ≥ 3) will be referred to the hospital's integrated care team following the same model as positive EPDS screens.

0 / 2Eligibility criteria met